A postal questionnaire inquiring about routine sedation and premedication practice for upper gastrointestinal endoscopy was sent to 1048 doctors. Of 665 appropriate returns, 81% were from consultant physicians and surgeons. Most endoscopists (90%) reported using an intravenous benzodiazepine for at least three quarters of endoscopies and 54% of physicians and 69% of surgeons always did so. Midazolam was the intravenous sedative used by a third of ali respondents and 13% also used an additional intravenous agent, usualiy pethidine. Over the previous two years a total of 119 respiratory arrests, 37 cardiac arrests, and 52 deaths were identified. Adverse outcomes were reported more frequently by consultant physicians, by those who 'titrated' the intravenous sedative, and by those who used an additional intravenous agent, but were reported equaliy frequently by endoscopists using midazolam and endoscopists using diazepam. There is an urgent need for a prospective study to identify the circumstances and risk factors associated with adverse outcomes related to endoscopy.
Gastrointestinal endoscopy is now widely available in Britain and is generally safe. On the basis of figures from the Trent region we estimate that about 400 000 are performed yearly in Britain.' Endoscopy is increasingly carried out on the 'old' old and the very sick. Most endoscopies are performed using intravenous sedation with a benzodiazepine which can occasionally produce severe hypoventilation and hypoxia.'-Adverse outcomes of endoscopy are uncommon but fatalities occur, as noted in several recent reports.7 '10 In the United States 66 deaths after sedation with intravenous midazolam have been reported to the Federal Drug Administration and the Committee on Safety of Medicines has received similar reports. " The pattern of premedication and sedation currently in use in Britain is largely unknown. There is also little information about the frequency of adverse outcomes associated with endoscopy. The aim ofthis study was to establish the pattern of current practice and to make a preliminary estimate of the frequency of adverse outcomes and their possible association with the use of particular drugs.
Methods
We sent an anonymous questionnaire to 1048 doctors who were identified as endoscopists from the mailing list of one of the major suppliers of endoscopy equipment in the United Kingdom (KeyMed Ltd). The our assessment of what is routine premedication and sedation practice by consultants. It also seems unlikely that the practice of their junior hospital staff would be appreciably different. The survey has established that in general premedication and sedation practice is fairly uniform. Over 90% of respondents use an intravenous benzodiazepine, mostly with local oropharyngeal anaesthesia but no other intravenous drugs. A few, however, reported routinely using other intravenous sedatives as well, usually pethidine, and these endoscopists also reported having more patients who required oxygen for hypoventilation. Taken together with the spontaneous comments we received, this supports the view that the use of pethidine for sedation for endoscopy is relatively hazardous. We found no evidence that adverse outcomes were more frequently experienced by respondents who used midazolam, but there were sufficient anecdotal statements to suggest that further study is necessary. Our finding that adverse outcomes were more frequently reported by consultant physicians and by those who 'titrate' sedation dose compared to those who give a bolus dose probably reflects differences in the characteristics of the respondents or a more cautious approach based on past experience rather than a causal relation.
As expected, severe hypoventilation was the most frequently reported adverse outcome. Recognition and recall of such episodes is likely to be more variable than for other outcomes to the extent that some might question whether they should be classified as adverse outcomes at all. Hypoventilation is likely to result in a degree of hypoxia, which in a small proportion of endoscopies is severe.5 6 Although the hypoxia is usually of no clinical relevance, the cardiac arrhythmias often observed during endoscopy occur most frequently during periods of maximum oxygen desaturation.5 1213 We suspect, therefore, that sedation practices that are more frequently associated with episodes of severe hypoventilation are also more likely to be associated with more serious adverse outcomes.
As far as the frequency of adverse outcomes is concerned, the reliability of retrospective statements, usually made without the help of records, are obvious. Nevertheless, we think it unlikely that such assessments will greatly inflate the number of such events, particularly the number of deaths. Our respondents recalled a total of 52 deaths over the past two years. From the estimates given of the number of endoscopies performed a month this represents a mortality of one in every 7500 to 11000 endoscopies. It 
